BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32180063)

  • 1. Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection.
    Beom SH; Shin SJ; Kim CG; Kim JH; Hur H; Min BS; Lee KY; Kim NK; Ahn JB
    Ann Surg Oncol; 2020 Aug; 27(8):2774-2783. PubMed ID: 32180063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
    Huang CS; Chen CY; Huang LK; Wang WS; Yang SH
    PLoS One; 2020; 15(6):e0233687. PubMed ID: 32502149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Carcinoembryonic Antigen as a Poor Prognostic Factor in Stage I-III Colorectal Cancer After Curative-Intent Resection: A Propensity Score Matching Analysis.
    Huang SH; Tsai WS; You JF; Hung HY; Yeh CY; Hsieh PS; Chiang SF; Lai CC; Chiang JM; Tang R; Chen JS
    Ann Surg Oncol; 2019 Jun; 26(6):1685-1694. PubMed ID: 30915591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment.
    Sun LC; Chu KS; Cheng SC; Lu CY; Kuo CH; Hsieh JS; Shih YL; Chang SJ; Wang JY
    BMC Cancer; 2009 Aug; 9():288. PubMed ID: 19691850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting long-term survival in colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Huh JW; Kim CH; Lim SW; Kim HR; Kim YJ
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1449-55. PubMed ID: 23765330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis.
    Lin PC; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Li AF; Chen WS; Chang SC
    Int J Colorectal Dis; 2012 Oct; 27(10):1333-8. PubMed ID: 22426691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors associated with primary cancer in curatively resected stage IV colorectal cancer.
    Huh JW; Lee WY; Park YA; Cho YB; Yun SH; Kim HC; Chun HK
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):435-41. PubMed ID: 24414039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of serum preoperative carcinoemberyonic antigen in colorectal cancer patients.
    El-Awady S; Lithy R; Morshed M; Khafagy W; Abd Monem H; Waleed O; Badr S; Fekry A; El Nakeeb A; Ghazy H; El Yamany M; Metwally T; El-Arman M; Farid M
    Hepatogastroenterology; 2009; 56(90):361-6. PubMed ID: 19579599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.
    Tong G; Xu W; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
    Cancer Med; 2018 Nov; 7(11):5327-5338. PubMed ID: 30302946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.
    Nakamura Y; Shida D; Tanabe T; Takamizawa Y; Imaizumi J; Ahiko Y; Sakamoto R; Moritani K; Tsukamoto S; Kanemitsu Y
    Cancer Med; 2020 Jan; 9(2):653-662. PubMed ID: 31799750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.
    Ramphal W; Boeding JRE; van Iwaarden M; Schreinemakers JMJ; Rutten HJT; Crolla RMPH; Gobardhan PD
    Int J Biol Markers; 2019 Mar; 34(1):60-68. PubMed ID: 30852955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.
    Li Destri G; Rubino AS; Latino R; Giannone F; Lanteri R; Scilletta B; Di Cataldo A
    Int Surg; 2015 Apr; 100(4):617-25. PubMed ID: 25875542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
    Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
    J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features and oncologic outcomes of colorectal cancer patients with extremely high carcinoembryonic antigen.
    Lee SY; Jo JS; Kim HJ; Kim CH; Ju JK; Kim YJ; Kim HR
    Int J Colorectal Dis; 2015 Jan; 30(1):63-9. PubMed ID: 25367182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.